Core Laboratories Inc Dossier - Source-backed chat

Core Laboratories Inc

CLBNYSE

SectorEnergy

IndustryOil & Gas Equipment & Services

Beta (adjusted)1.03

Intrinsic Value $15.19median of 6 methods · middle span $10-$18based on filings through 30 Jun 2026

Market Price $9.76Price as of 1 Oct 2026

Significantly undervaluedIntrinsic value is 56% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (+56%)

Data confidence Sign in to view data confidence

Market Cap $447.8M

Enterprise Value $539M

Shares Outstanding 46.5M diluted

Moat Rating Narrow

Next Earnings Date21 Oct 2026

Last ex-dividend11 May 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Core Laboratories Inc. (CLB) remains a premier, asset-light provider of proprietary reservoir description and production enhancement services. However, near-term performance is heavily pressured by exogenous headwinds, including geopolitical conflicts in the Middle East and severe weather disruptions across North America and Europe. While structural underinvestment in global oil and gas reserves and rising natural decline rates support long-term demand for reservoir optimization, the company's elevated valuation multiples relative to near-term free cash flow and earnings growth justify a Hold rating until operational margins show a clearer path to recovery.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets3 analysts · as of 18 Aug 2026

Low · most bearish analyst$11.00

Mean target$15.50

High · most bullish analyst$22.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The bear case assumes prolonged geopolitical conflict in the Middle East, causing persistent disruptions to regional laboratory operations and shipping routes. Simultaneously, a sharper-than-expected decline in U.S. land completion activity and sustained soft commodity prices compress margins in the Production Enhancement segment, keeping quarterly EPS depressed and limiting free cash flow.

Base CaseCentral scenario

The base case assumes a gradual stabilization of geopolitical tensions in the Middle East, allowing delayed energetic product shipments to resume and maritime hydrocarbon assay demand to rebound. North American land activity remains stable but flat, while international and offshore projects drive modest sequential growth. Operating margins recover toward historical double-digit levels as capacity utilization improves.

Bull CaseUpside scenario

The bullish case for Core Laboratories centers on its strong international and offshore project pipeline, particularly in the Middle East, Asia Pacific, and West Africa. As a leading provider of proprietary and patented reservoir description and production enhancement services, the company is highly leveraged to a multi-year international capital expenditure cycle. Sustained global demand for crude oil and accelerating natural decline rates in existing producing fields reinforce the long-term necessity for operators to invest in Core Lab's diagnostic and reservoir optimization technologies to maximize recovery rates.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Asset-light business model that promotes capital efficiency and supports a high long-term Return on Invested Capital (ROIC).
Proprietary and patented technology portfolio (e.g., diagnostic tracers, advanced rock typing) essential for operators to offset natural decline rates in existing fields.
Strong leverage to the multi-year international and offshore oil and gas development cycle, which is less volatile than North American land activity.

Key Investment Risks

High sensitivity to geopolitical disruptions, particularly in the Middle East, which directly impacts regional laboratory operations and product logistics.
Exposure to cyclical fluctuations in North American unconventional completion activity and land rig counts.
Relatively low near-term operating margins and elevated valuation multiples on a Price-to-Free-Cash-Flow basis.

Thesis Invalidation Triggers

A sustained drop in global crude oil prices below $60/bbl, leading to widespread capital expenditure cuts by major international and national oil companies.
Permanent structural damage to key laboratory infrastructure in the Middle East due to escalating regional conflicts.
Failure to achieve sequential margin expansion in the Reservoir Description segment during the second half of 2026.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.